D
Greenwich LifeSciences, Inc. GLSI
$11.67 -$0.26-2.18% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -76.08% -79.37% -77.57% -17.45% -15.30%
Total Depreciation and Amortization 0.00% 0.00% 0.00% 0.00% 0.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 284.89% 244.95% 205.02% 0.00% -6.49%
Change in Net Operating Assets -68.37% 581.10% 3,916.83% 817.68% 1,352.21%
Cash from Operations -25.33% -9.16% -12.16% -16.54% -8.67%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 43.64% 1,425.34% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 43.64% 1,425.34% -- -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -10.23% 56.97% 55.28% 48.86% 40.43%